Indefinite Delivery Contract 36E79726D0024
Award Date 5/30/26
Last Date to Order 5/29/27
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to DR Reddy's Laboratories, Inc., a multinational pharmaceutical manufacturer, to supply allopurinol tablets in various strengths to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award IDC has a base year plus four one-year option periods, with a total ceiling value of $26,069,655.90. The contract will utilize the...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026. The contract will supply aripiprazole tablets in various package sizes to the VA,...
- Xlcare Pharmaceuticals Inc. (UEI: MEAUS5WHBJJ7) was awarded a single-award Indefinite Delivery Contract by the National Acquisition Center, a civilian federal agency, on May 10, 2026, to supply Montelukast 10mg tablets to multiple federal healthcare entities. The contract carries a ceiling value of $24.8 million and encompasses a five-year performance period consisting of a base year (May 10, 2026 through May 9, 2027) plus four one-year option periods, with an ultimate completion date of May...
- This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The $11,065,099.45 single-award contract is for the supply of Oxcarbazepine tablets in various strengths and package sizes to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The one-year base period runs from October 14, 2024 to October 13, 2025, with four...
- This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The contract has a ceiling value of $1,423,620.00 and a period of performance from December 23, 2021 to December 22, 2026, with a one-year base period and four one-year option periods. The contract is for the delivery of dutasteride...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned small disadvantaged business, to provide Topiramate tablets over a 1-year base period and four 1-year option periods, for a total potential contract value of $14,134,788.05. The contract will support the VA, Department of Defense, Bureau of Prisons, and Indian Health Service by providing an uninterrupted supply of Topiramate tablets in...
- This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business certified as an economically disadvantaged woman-owned small business. The single-award IDC has a ceiling value of $28,973,375.80 and a base period of one year from June 26, 2022 to June 25, 2023, with four one-year option periods. The contract is for the supply of delayed-release pantoprazole...
- This indefinite delivery contract represents a single-award procurement executed on May 13, 2023, by the National Acquisition Center, a civilian federal agency, to supply Lacosamide injections to the U.S. government. The prime contractor, Xlcare Pharmaceuticals Inc. (UEI: MEAUS5WHBJJ7), is a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business certified entity. The contract carries a ceiling value of $761,850.00 and encompasses a base ordering...
- This single-award Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc. for the supply of Montelukast NA Tablets. The contract has a 1-year base period with four 1-year option periods, for a total potential period of performance through May 9, 2026. The contract ceiling value is $23,863,543.01. The contract aims to provide an uninterrupted source of Montelukast NA Tablets in various package...